Kamilė Piekutė¹

¹Lithuanian University of Health Sciences, Academy of Medicine, Kaunas, Lithuania

Abstract

Trichomoniasis is a sexually transmitted disease that is caused by vaginal trichomonas. Trichomoniasis is associated with potentially serious complications such as: preterm birth, acquisition and transmission of human immunodeficiency virus. Many infected women experience minimal symptoms or no symptoms and most male infections are asymptomatic. If the disease is symptomatic, women usually complain: greenish-yellow, profuse, frothy, unpleasant-smelling vaginal discharge, painful urination, burning, itching in the genital area, redness and swelling of the vulva and vagina. Meanwhile, the main complaints of men are thin, watery or mucous urethral discharge, irritation or burning inside the urethra, painful urination and itching. T.vaginalis infection in European countries is mainly diagnosed by native wet smear microscopy based on parasite morphology and motility.  Drugs approved for the treatment of trichomoniasis include metronidazole and tinidazole. The standard therapy is metronidazole or tinidazole, taken as a single oral dose of 2 g or intravenously if necessary. The aim of this article is to discuss the clinical signs, diagnosis and treatment of trichomoniasis. Standard therapy consists of metronidazole or tinidazole taken as a single oral dose of 2 g or, if necessary, intravenously. This article reviews the clinical signs, diagnosis and treatment of trichomoniasis.

Keywords: trichomoniasis, infection, sexually transmitted disease.